Anthracycline-induced hypertension in pediatric cancer survivors: unveiling the long-term cardiovascular risks
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Anthracycline-induced hypertension in pediatric cancer survivors: unveiling the long-term cardiovascular risks ; volume:76 ; number:1 ; day:7 ; month:6 ; year:2024 ; pages:1-12 ; date:12.2024
The Egyptian heart journal ; 76, Heft 1 (7.6.2024), 1-12, 12.2024
- Creator
-
Taghdiri, Andia
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s43044-024-00506-1
- URN
-
urn:nbn:de:101:1-2408151252032.819583105318
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Taghdiri, Andia
- SpringerLink (Online service)
Other Objects (12)
Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors
Early markers of cardiovascular injury in childhood leukaemia survivors treated with anthracycline chemotherapy
Resting and exercise arterial dysfunction in anthracycline-treated adult survivors of childhood cancers
Cardiovascular toxicities after anthracycline and VEGF-targeted therapies in adolescent and young adult cancer survivors
Approaches for monitoring and treating cardiomyopathy among cancer survivors following anthracycline or thoracic radiation treatment
Cardiac mechanisms for low aerobic power in anthracycline treated, older, long-term breast cancer survivors
Anthracycline Chemotherapy and Cardiotoxicity
Left Ventricle Size Correlates with Peak Exercise Capacity in Pediatric Cancer Survivors Exposed to Anthracycline Chemotherapy
Correction: Approaches for monitoring and treating cardiomyopathy among cancer survivors following anthracycline or thoracic radiation treatment
Unveiling the metabolic landscape of pulmonary hypertension: insights from metabolomics
Associations of combined genetic and lifestyle risks with hypertension and home hypertension
Asymptomatic systolic dysfunction on contemporary echocardiography in anthracycline-treated long-term childhood cancer survivors: a systematic review
Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors
Early markers of cardiovascular injury in childhood leukaemia survivors treated with anthracycline chemotherapy
Resting and exercise arterial dysfunction in anthracycline-treated adult survivors of childhood cancers
Cardiovascular toxicities after anthracycline and VEGF-targeted therapies in adolescent and young adult cancer survivors
Approaches for monitoring and treating cardiomyopathy among cancer survivors following anthracycline or thoracic radiation treatment
Cardiac mechanisms for low aerobic power in anthracycline treated, older, long-term breast cancer survivors
Anthracycline Chemotherapy and Cardiotoxicity
Left Ventricle Size Correlates with Peak Exercise Capacity in Pediatric Cancer Survivors Exposed to Anthracycline Chemotherapy
Correction: Approaches for monitoring and treating cardiomyopathy among cancer survivors following anthracycline or thoracic radiation treatment
Unveiling the metabolic landscape of pulmonary hypertension: insights from metabolomics
Associations of combined genetic and lifestyle risks with hypertension and home hypertension
Asymptomatic systolic dysfunction on contemporary echocardiography in anthracycline-treated long-term childhood cancer survivors: a systematic review
Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors
Early markers of cardiovascular injury in childhood leukaemia survivors treated with anthracycline chemotherapy
Resting and exercise arterial dysfunction in anthracycline-treated adult survivors of childhood cancers
Cardiovascular toxicities after anthracycline and VEGF-targeted therapies in adolescent and young adult cancer survivors
Approaches for monitoring and treating cardiomyopathy among cancer survivors following anthracycline or thoracic radiation treatment
Cardiac mechanisms for low aerobic power in anthracycline treated, older, long-term breast cancer survivors
Anthracycline Chemotherapy and Cardiotoxicity
Left Ventricle Size Correlates with Peak Exercise Capacity in Pediatric Cancer Survivors Exposed to Anthracycline Chemotherapy
Correction: Approaches for monitoring and treating cardiomyopathy among cancer survivors following anthracycline or thoracic radiation treatment
Unveiling the metabolic landscape of pulmonary hypertension: insights from metabolomics
Associations of combined genetic and lifestyle risks with hypertension and home hypertension